Bayer MaterialScience Plans $120 Investment at Texas Manufacturing Plant
05/18/2011
The planned U.S. $120 million investment is designed to improve the reliability of the infrastructure throughout the site.
The investments signal a commitment to Baytown by Bayer MaterialScience and are intended to help support anticipated regional growth. The press release did not mention how many additional jobs (if any) are projected to be created.
Ironically, any creation of jobs could lead to challenges for Bayer Material Science as the company already has trouble finding skilled workers for its Baytown facility. In a May 6 article posted on WSJ.com, Gregory Babe, chief executive of Bayer AG's U.S. business, remarked that the skill shortage "is a real issue, and it's going to get much worse."
The article goes on to mention that Bayer has had particular trouble filling positions at its plastics plant in Baytown, Texas.
Bayer, this summer, will for the first time hire interns to learn how to operate machinery at the Baytown plant in the hopes of ultimately recruiting capable workers for full-time employment.
Project Announcements
Johnson & Johnson Expands Wilson County, North Carolina, Production Operations
01/16/2026
Solstice Advanced Materials Expands Chesterfield County, Virginia, Manufacturing Operations
01/16/2026
TransMedics Group Plans Somerville, Massachusetts, Headquarters Operations
01/16/2026
AVAIO Digital Partners Plans Pulaski County, Arkansas, Data Center Operations
01/14/2026
Lattice Materials Expands Bozeman, Montana, Manufacturing Operations
01/14/2026
xAI Plans Southaven, Mississippi, Data Center Operations
01/14/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025